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practice. Incremental cost-effectiveness ratios are preferred to benefit-to-cost ratios because benefit-to-cost ratios only include monetary benefits rather than health benefits. The cost-effectiveness analysis was not a full incremental analysis, but there were no deaths with either of the proposed strategies, so the cheaper one (vaccination of one-to-twoyear-olds) was preferred. If quality-adjusted life-years were used, the two strategies would not have been equally effective, due to differences in complication rates. Univariate sensitivity analyses were performed, but only for the benefit-to-cost ratio and not for the incremental cost-effectiveness results. Multivariate and probabilistic sensitivity analyses would have more thoroughly assessed the impact of parameter uncertainty on the results. The reporting was generally good, and the authors discussed the strengths and limitations of their model.
